CN104965033B - 一种苍柏袪痛制剂hplc指纹图谱的测定方法 - Google Patents
一种苍柏袪痛制剂hplc指纹图谱的测定方法 Download PDFInfo
- Publication number
- CN104965033B CN104965033B CN201510410688.5A CN201510410688A CN104965033B CN 104965033 B CN104965033 B CN 104965033B CN 201510410688 A CN201510410688 A CN 201510410688A CN 104965033 B CN104965033 B CN 104965033B
- Authority
- CN
- China
- Prior art keywords
- weight portion
- acetonitrile
- phosphoric acid
- radix
- cypress
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 41
- 230000036407 pain Effects 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title abstract description 16
- 238000004128 high performance liquid chromatography Methods 0.000 title abstract 5
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 66
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims abstract description 50
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims abstract description 25
- 238000012360 testing method Methods 0.000 claims abstract description 21
- 239000003814 drug Substances 0.000 claims abstract description 20
- 238000010828 elution Methods 0.000 claims abstract description 15
- 238000001514 detection method Methods 0.000 claims abstract description 10
- 229940079593 drug Drugs 0.000 claims abstract description 8
- FGDQGIKMWOAFIK-UHFFFAOYSA-N acetonitrile;phosphoric acid Chemical compound CC#N.OP(O)(O)=O FGDQGIKMWOAFIK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims abstract description 5
- 241000218691 Cupressaceae Species 0.000 claims description 32
- 238000007639 printing Methods 0.000 claims description 24
- 238000000605 extraction Methods 0.000 claims description 15
- 238000003556 assay Methods 0.000 claims description 11
- 239000004615 ingredient Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 4
- 238000002137 ultrasound extraction Methods 0.000 claims description 4
- 150000002825 nitriles Chemical class 0.000 claims description 2
- 239000000243 solution Substances 0.000 abstract description 23
- 230000014759 maintenance of location Effects 0.000 abstract description 10
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 50
- 239000000523 sample Substances 0.000 description 37
- 239000013558 reference substance Substances 0.000 description 23
- 239000000203 mixture Substances 0.000 description 21
- RBBVPNQTBKHOEQ-KKSFZXQISA-O Phellodendrine Chemical compound C1CC2=CC(OC)=C(O)C=C2[C@H]2[N@+]1(C)CC(C=C(C(=C1)O)OC)=C1C2 RBBVPNQTBKHOEQ-KKSFZXQISA-O 0.000 description 17
- WVTKBKWTSCPRNU-KYJUHHDHSA-N (+)-Tetrandrine Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-KYJUHHDHSA-N 0.000 description 16
- 239000012071 phase Substances 0.000 description 11
- DUAGQYUORDTXOR-GPQRQXLASA-N Gentiopicrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](C=C)C2=CCOC(=O)C2=CO1 DUAGQYUORDTXOR-GPQRQXLASA-N 0.000 description 10
- DUAGQYUORDTXOR-WULZUDSJSA-N Gentiopicrin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1[C@@H](C=C)C=2C(C(=O)OCC=2)=CO1 DUAGQYUORDTXOR-WULZUDSJSA-N 0.000 description 10
- 239000003513 alkali Substances 0.000 description 10
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride (TN) Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 description 8
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 8
- WVTKBKWTSCPRNU-UHFFFAOYSA-N rac-Tetrandrin Natural products O1C(C(=CC=2CCN3C)OC)=CC=2C3CC(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2CC2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000012488 sample solution Substances 0.000 description 7
- 239000002775 capsule Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 201000005569 Gout Diseases 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000012467 final product Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000003643 water by type Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 238000007905 drug manufacturing Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 230000000146 antalgic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 239000012982 microporous membrane Substances 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000006344 Churg-Strauss Syndrome Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000018428 Eosinophilic granulomatosis with polyangiitis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000501719 Gentiana straminea Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000032514 Leukocytoclastic vasculitis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 238000012395 formulation development Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012372 quality testing Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510410688.5A CN104965033B (zh) | 2015-07-14 | 2015-07-14 | 一种苍柏袪痛制剂hplc指纹图谱的测定方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510410688.5A CN104965033B (zh) | 2015-07-14 | 2015-07-14 | 一种苍柏袪痛制剂hplc指纹图谱的测定方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104965033A CN104965033A (zh) | 2015-10-07 |
CN104965033B true CN104965033B (zh) | 2017-01-18 |
Family
ID=54219080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510410688.5A Expired - Fee Related CN104965033B (zh) | 2015-07-14 | 2015-07-14 | 一种苍柏袪痛制剂hplc指纹图谱的测定方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104965033B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110731962B (zh) * | 2018-07-18 | 2022-05-20 | 中国医学科学院药物研究所 | 小檗碱、黄连碱或其活性代谢产物、及其盐在预防和/或治疗尿酸性肾病药物中的应用 |
CN111175429B (zh) * | 2020-01-07 | 2022-06-14 | 贵州长生药业有限责任公司 | 杀菌止痒洗剂指纹图谱的建立方法 |
CN113237972A (zh) * | 2021-04-30 | 2021-08-10 | 江苏卫生健康职业学院 | 具有抗痛风作用的中药组合物及其指纹图谱的检测方法 |
CN115166117B (zh) * | 2022-08-04 | 2024-01-26 | 成都中医药大学附属医院 | 一种治疗放化疗后消化道复合症状群的药物的hplc检测方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI285262B (en) * | 2005-06-20 | 2007-08-11 | Dev Center Biotechnology | Characteristic mass spectrum fingerprinting setting method and rapid identification method of Chinese herb medicine and prescription |
-
2015
- 2015-07-14 CN CN201510410688.5A patent/CN104965033B/zh not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
二妙丸指纹图谱研究;孙兆姝等;《中成药》;20090831;第31卷(第8期);1155-1158 * |
二妙散中苍术黄柏不同剂量配伍的指纹图谱研究;王琰等;《时珍国医国药》;20141231;第25卷(第4期);摘要,第88页左栏第1段,第2.1.2、2.2节 * |
加味四妙丸有效部位群HPLC指纹图谱归属分析及谱效关系研究;钱俊等;《世界科学技术-中医药现代化》;20071231;第9卷(第1期);40-45 * |
Also Published As
Publication number | Publication date |
---|---|
CN104965033A (zh) | 2015-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106501434B (zh) | 一种双和汤标准汤的hplc指纹图谱测定方法 | |
CN104965033B (zh) | 一种苍柏袪痛制剂hplc指纹图谱的测定方法 | |
CN105806975A (zh) | 一种银翘散uplc指纹图谱的建立方法 | |
CN106324161B (zh) | 治疗糖尿病肾病的中药组合物的质量检测方法 | |
CN106483213A (zh) | 桃核承气汤组合物指纹图谱的建立方法及指纹图谱 | |
CN106483227A (zh) | 桃核承气汤组合物的质量控制方法 | |
CN106053700B (zh) | 一种首乌益智胶囊的指纹图谱测定方法 | |
CN103399094A (zh) | 一种消癥丸制剂的指纹图谱检测方法 | |
CN114200045A (zh) | 一种蠲痹汤制剂活性成分的测定方法 | |
CN107589191A (zh) | 金贝口服液hplc 指纹图谱建立和检测方法 | |
CN108459090B (zh) | 济川煎组合物的质量控制方法 | |
CN104316613B (zh) | 一种疏风解毒胶囊指纹图谱的建立方法 | |
CN117233306B (zh) | 一种金丹附延颗粒指纹图谱建立及其成分含量测定方法 | |
CN102539599B (zh) | 一种强肝药物的检测方法 | |
CN104155383B (zh) | 青蒲颗粒的检测方法 | |
CN106153812A (zh) | 一种治疗子宫内膜异位症的中药制剂的检测方法 | |
CN104833751B (zh) | 小儿感冒宁糖浆水提液hplc标准指纹图谱的建立方法及其应用 | |
CN101816753B (zh) | 一种治疗感冒的复方制剂的质量检测方法 | |
CN103230453A (zh) | 一种茵陈蒿汤配方颗粒及其制备方法和检测方法 | |
CN110464825A (zh) | 一种地黄饮子药物组合物、制备方法、检测方法 | |
CN109884226A (zh) | 一种杭白芍有效成分的提取方法 | |
CN106018647B (zh) | 一种建立葵花盘hplc标准指纹图谱的方法 | |
CN105044260B (zh) | 玉屏风制剂指纹图谱的构建方法和检测方法 | |
CN104458954B (zh) | 一种菟丝子配方颗粒指纹图谱及其建立方法 | |
CN103575823A (zh) | 一种糖敏灵制剂中8种化学成分的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Jia Zhong Inventor after: Wu Jing Inventor after: Liu Hongyan Inventor before: Jia Zhong Inventor before: Liu Hongyan Inventor before: Wu Jing Inventor before: Yuan Wenjun Inventor before: Liu Yuan Inventor before: Liu Lina Inventor before: Wu Danfeng |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170816 Address after: 730000 Industrial incubation building, Lanzhou New District, Gansu, Lanzhou 0812 Patentee after: Zhang Xingang Address before: 730000 Lanzhou Pulmonary Hospital, North Binhe Road, Chengguan District, Gansu, Lanzhou Patentee before: Jia Zhong |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180402 Address after: 734000, room third, No. 001, No. 39, Jinchang North Road, Chengguan District, Lanzhou City, Gansu Patentee after: Gansu Dession Technology Development Co. Ltd. Address before: 730000 Industrial incubation building, Lanzhou New District, Gansu, Lanzhou 0812 Patentee before: Zhang Xingang |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170118 Termination date: 20210714 |
|
CF01 | Termination of patent right due to non-payment of annual fee |